Significant Growth in Suboxone Tooth Decay MDL
In a notable development, the number of cases within the newly formed Suboxone tooth decay class action MDL has surged, more than tripling in the span of just one month. At the onset of April, the MDL commenced with a modest 44 pending cases. However, with the addition of 161 new cases throughout the month, the total caseload has skyrocketed to 205, indicating a swift and substantial expansion of the litigation. This rapid growth trajectory aligns with expectations for early-stage proceedings within this MDL.
